Published December 19, 2022
| Version v1
Dataset
Restricted
TLRagonist + PDL1 treated PBMC
Description
PBMC from HIV infected individuals were treated with TLRagonists +/- PDL1 blockade to check their impact on effector HIV-specific T cell responses.